Melissa B. Epperly, CFO: Zentalis Pharmaceuticals ZNTL Sell · Filed 23/02/14

Trade details

Type: Insider sale
Amount: $104,435.46
Shares · price: 5,227 sh · $19.98 a share
Held after: 392,048 sh
Stock: Zentalis Pharmaceuticals ZNTL
Person: Melissa B. EpperlyCFO
Trade date: 23/02/14
Filed: 23/02/14
Days to filing: 0 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Zentalis Pharmaceuticals trades, last 26 weeks

What else happened in Zentalis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/15~23/03/16

Melissa B. Epperly's recent trades

Melissa B. EpperlyDirector
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$930.7K
22,688 sh
$930.7K
Filed 09/15
Traded 09/15
Melissa B. EpperlyDirector
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$604.7K
17,750 sh
$604.7K
Filed 06/29
Traded 06/29
Melissa B. EpperlyDirector
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$1.2M
41,861 sh
$1.2M
Filed 03/18
Traded 03/16
Melissa B. EpperlyDirector
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$1.2M
41,861 sh
$1.2M
Filed 03/16
Traded 03/16
Melissa B. EpperlyCFO
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$29.4K
2,573 sh
$29.4K
Filed 24/02/12
Traded 24/02/12

Melissa B. Epperly, CFO — sold $104.4K of Zentalis Pharmaceuticals ZNTL · 1.3% of holdings | Whalegun